Patents by Inventor Allan Fischman

Allan Fischman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Synthetic peptides for arterial imaging
    Patent number: 5972890
    Abstract: Vascular disease including asymptomatic atherosclerosis can be diagnosed by administering a synthetic peptide or peptide analog having an affinity for, and propensity to accumulate at, a site of vascular injury to a patient, and then detecting the location of the peptide or peptide analog within the patient's vascular system. The synthetic peptide or peptide analog may include an amino acid sequence sufficiently duplicative of the amino acid sequence of a region of either the apolipoprotein B, apolipoprotein A-I, or elastin proteins such that the peptide or peptide analog accumulates at a site of vascular injury.
    Type: Grant
    Filed: February 28, 1995
    Date of Patent: October 26, 1999
    Assignee: New England Deaconess Hospital Corporation
    Inventors: Robert S. Lees, Ann M. Lees, Allan Fischman, Ing-Lung Shih, Mark A. Findeis
  • Synthetic peptides for arterial imaging at vascular imaging sites
    Patent number: 5955055
    Abstract: Vascular disease including asymptomatic atherosclerosis can be diagnosed by administering a synthetic peptide or peptide analog having an affinity for, and propensity to accumulate at, a site of vascular injury to a patient, and then detecting the location of the peptide or peptide analog within the patient's vascular system. The synthetic peptide or peptide analog may include an amino acid sequence sufficiently duplicative of the amino acid sequence of a region of either the apolipoprotein B, apolipoprotein A-I, or elastin proteins such that the peptide or peptide analog accumulates at a site of vascular injury.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: September 21, 1999
    Assignee: New England Deaconess Hospital Corporation
    Inventors: Robert S. Lees, Ann M. Lees, Allan Fischman, Ing-Lung Shih, Mark A. Findeis
  • Synthetic peptides for arterial imaging
    Patent number: 5726153
    Abstract: Vascular disease including asymptomatic atherosclerosis can be diagnosed by administering a synthetic peptide or peptide analog having an affinity for, and propensity to accumulate at, a site of vascular injury to a patient, and then detecting the location of the peptide or peptide analog within the patient's vascular system. The synthetic peptide or peptide analog may include an amino acid sequence sufficiently duplicative of the amino acid sequence of a region of either the apolipoprotein B, apolipoprotein A-I, or elastin proteins such that the peptide or peptide analog accumulates at a site of vascular injury.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: March 10, 1998
    Assignee: New England Deaconess Hospital Corporation
    Inventors: Robert S. Lees, Ann M. Lees, Allan Fischman, Ing-Lung Shih, Mark A. Findeis